CBD.U
vs
S&P 500
CBD.U
S&P 500
Over the past 12 months, CBD.U has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.
Stocks Performance
CBD.U vs S&P 500
Performance Gap
CBD.U vs S&P 500
Performance By Year
CBD.U vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Hempfusion Wellness Inc
Glance View
HempFusion Wellness, Inc. manufactures pain relief, wound ointment and CBD hemp products and sells through online. The company is headquartered in Sebastopol, California. The company went IPO on 2021-01-06. The firm manufactures and distributes Hemp-based cannabidiol (CBD) and probiotic products. The Company’s HempFusion product include tinctures, capsules, and topical creams and gel products. Planned HempFusion product categories include beverages, gummies and pet products. Its Probulin branded products, which are not made with Hemp extracts, include probiotic enzyme and digestive capsules and topical products. Planned Probulin products include capsules, beverages and gummies. The Company’s branded HF Labs and Biome Research products are versions of the Company’s Hemp extract-based and probiotic products. The Company’s products are distributed through its e-commerce websites, doctor practitioners and a variety of Food, Drug, Mass Merchant, and Warehouse Club (FDMC) retailers.